close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by NAMSA

NAMSA Acquires the U.S. Medical Device Testing Operations of WuXi AppTec, Solidifying its Position as the Leader in MedTech Testing and Clinical Research
From NAMSA
Via Business Wire
NAMSA and TERUMO Announce Strategic Outsourcing Partnership
From NAMSA
Via Business Wire
NAMSA Acquires German Based CRI to Expand Clinical Research and Geographic Reach Across Europe
From NAMSA
Via Business Wire
Global MedTech CRO, NAMSA, Announces Strategic Outsourcing Partnership With Terumo Aortic
From NAMSA
Via Business Wire
NAMSA Expands MedTech Portfolio in Market Intelligence and Customer Research Services through its Acquisition of EU-Based SUAZIO
From NAMSA
Via Business Wire
NAMSA Transforms Integrated MedTech Commercialization Solution: the NAMSA APEX Program™
From NAMSA
Via Business Wire
NAMSA Acquires UK-Based Perfectus Biomed Group to Enhance Customized Microbiological Solutions
From NAMSA
Via Business Wire
NAMSA and InspireMD Announce Strategic Outsourcing Partnership to Accelerate New Product Development
From NAMSA
Via Business Wire
Tickers NSPR
NAMSA to Acquire European-Based Medanex Clinic to Expand Early-Stage Preclinical Research Capabilities
From NAMSA
Via Business Wire
NAMSA Announces Intent to Acquire Contract Research Organization, ÅKRN
From NAMSA
Via Business Wire
NAMSA Expands Minneapolis Preclinical Laboratory to Meet Industry Demand for MedTech Research and Development Solutions
From NAMSA
Via Business Wire
NAMSA Acquires Leading Clinical Research Organization Clinlogix to Enhance Therapeutic Expertise and Global Footprint
From NAMSA
Via Business Wire
NAMSA First to Receive FDA ASCA Accreditation for Medical Device Biocompatibility Testing
From NAMSA
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today